# BlueWhale Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluewhale-bio

- Industry: Biotechnology
- Headquarters: Philadelphia, US
- Total disclosed funding: $18M
- Latest round: Seed (Sep 7, 2023)
- Investors on record: 3

## About

Based in Pennsylvania, US, and founded in 2023, BlueWhale Bio, Inc. is a spinout from the University of Pennsylvania and operates as a biotechnology company that develops platforms for the delivery of cell and gene therapy. In September 2023, BlueWhale Bio raised USD 18 million in seed funding led by Danaher Corporation, with participation from Novalis LifeSciences and Hillhouse Capital Group. As of September 2023, the company is led by its CEO Peter Keller.

BlueWhale Bio, Inc. developing a technology platform aimed at accelerating the delivery of cell and gene therapy benefits to patients while simultaneously reducing costs.

The company plans to use the seed funding to expand operations and its R&D sector.

## Funding rounds

- Seed, Sep 7, 2023, $18M — Danaher Corporation, Hillhouse Investment, Novalis LifeSciences

## Investors

- Danaher Corporation — Seed
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Seed
- Novalis LifeSciences (https://capitalatlas.ai/funds/novalis-lifesciences) — Seed